TITLE

Ursodiol for All?

AUTHOR(S)
Lee, Scott D.; Surawicz, Christina M.
PUB. DATE
December 2001
SOURCE
American Journal of Gastroenterology;Dec2001, Vol. 96 Issue 12, p3437
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The authors undertook retrospective cross-sectional study to determine the relationship between the use of ursodiol and dysplasia in patients with ulcerative colitis and primary sclerosing cholangitis (PSC). All patients with ulcerative colitis and PSC were evaluated for the presence of dysplasia in biopsies taken during a previously established colonoscopic surveillance program. In the program, patients underwent colonoscopy every 3 yr with random four-quadrant biopsies (average of 47 biopsies/session). If low grade dysplasia indefinite for dysplasia or aneuploidy was found at any time, patients then had yearly colonoscopies. Patients were included in the ursodiol group if they had used ursodiol at any time before the development of dysplasia. The primary endpoint was the development of dysplasia. Fifty-nine patients met the entry criteria. Of these, 41 had taken ursodiol at some time and 18 had never taken ursodiol. The development of dysplasia was significantly less common in patients who had received ursodiol (odds ratio = 0.18, 95% CI = 0.05-0.61). The development of dysplasia was not related to other medications, including sulfasalazine, 5-aminosalicylic acid, prednisone, cyclosporine, azathioprine, and methotrexate. The protective effect of ursodiol against the development of dysplasia remained after adjusting for sex, age at onset of colitis, duration of colitis, duration of PSC, Child-Pugh class, and use of sulfasalazine. An increased risk for the development of dysplasia was also noted in those patients who had onset of colitis at a younger age. The authors concluded that ursodiol use is associated with lower frequency of colonic dysplasia in patients with ulcerative colitis and PSC. They suggest that a prospective randomized trial evaluating the chemoprotective effect of ursodiol is warranted.
ACCESSION #
17611946

 

Related Articles

  • DYSPLASIA IN ULCERATIVE COLITIS IS USUALLY VISIBLE AT COLONOSCOPY. Rutter, M.D.; Wilkinson, K.H.; Saunders, B.P. // Gut;Apr2003 Supplement 1, Vol. 52, pA4 

    Background and Aim: During colonoscopic surveillance for dysplasia in longstanding extensive ulcerative colitis (UC), multiple non-targeted "random" biopsies of colonic mucosa are advised, based on historical data suggesting dysplasia may only be detectable microscopically. We aimed to assess...

  • Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Rutter, M. D.; Saunders, B. P.; Schofield, G.; Forbes, A.; Price, A. B.; Talbot, I. C. // Gut;Feb2004, Vol. 53 Issue 2, p256 

    Background and aims: Colonoscopic surveillance for cancer in longstanding extensive ulcerative colitis relies heavily on non-targeted mucosal biopsies. Chromoendoscopy can aid detection of subtle mucosal abnormalities. We hypothesised that routine pancolonic indigo carmine dye spraying would...

  • Efficacy of surveillance and molecular markers for detection of ulcerative colitis-associated colorectal neoplasia. Fujii, Shigehiko; Fujimori, Takahiro; Chiba, Tsutomu; Terano, Akira // Journal of Gastroenterology;2003, Vol. 38 Issue 12, p1117 

    ‘

  • Delayed Perforation of the Cecum after Diagnostic Biopsy. Loggan, Michael; Moeller, Donald D. // American Journal of Gastroenterology;Dec1984, Vol. 79 Issue 12, p933 

    Colonoscopy is an important diagnostic study in monitoring patients with chronic ulcerative colitis for carcinoma and dysplasia (precancer). A 76-year-old woman with chronic ulcerative colitis of 13 years' duration underwent colonoscopy. Biopsies were obtained at 10-cm intervals throughout the...

  • Worsening Risk for the Development of Dysplasia or Cancer in Patients with Chronic Ulcerative Colitis. Lashner, Bret A.; Provencher, Kimberly S.; Bozdech, John M.; Brzezinski, Aaron // American Journal of Gastroenterology;Mar1995, Vol. 90 Issue 3, p377 

    Objectives: Patients with ulcerative colitis (UC) are at increased risk for developing dysplasia or cancer (neoplasia) and are usually offered colonoscopic surveillance to reduce their risk of cancer-related mortality. The causes of neoplasia may be related to features of UC (the extent,...

  • Is Colonoscopy Alone Sufficient to Screen for Ulcerative Colitis-associated Colorectal Carcinoma? World J. Surg. Vol. 27, No. 5, May 2003. Bruewer, Matthias; Krieglstein, Christian F.; Utech, Markus; Bode, Marc; Rijcken, Emile; Anthoni, Christoph; Laukoetter, Mike G.; Schuermann, Guido; Senninger, Norbert // World Journal of Surgery;May2003, Vol. 27 Issue 5, p611 

    Patients with ulcerative colitis (UC) are at increased risk for colorectal carcinoma (CAC). Despite the fact that patients at risk are followed closely by colonoscopy to screen for dysplasia, the prevalence of CAC is still unacceptably high. The aim of this study was to evaluate the prevalence...

  • Adenocarcinoma in Strictures of Ulcerative Colitis without Antecedent Dysplasia by Colonoscopy. Reiser, Janet R.; Waye, Jerome D.; Janowitz, Henry D.; Harpaz, Noam // American Journal of Gastroenterology;Jan1994, Vol. 89 Issue 1, p119 

    We report three patients with chronic ulcerative colitis and colonic strictures that were found to harbor advanced adenocarcinomas despite previous endoscopic examinations that had failed to demonstrate dysplasia or carcinoma. This experience calls into question the reliability of endoscopic...

  • Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Hata, K.; Watanabe, T.; Kazama, S.; Suzuki, K.; Shinozaki, M.; Yokoyama, T.; Matsuda, K.; Muto, T.; Nagawa, H. // British Journal of Cancer;10/6/2003, Vol. 89 Issue 7, p1232 

    Patients with long-standing ulcerative colitis (UC) are known to have an increased risk for the development of colorectal cancer (CRC). The aim of this study was to clarify the cumulative risk for the development of dysplasia or invasive cancer and the effectiveness of surveillance colonoscopy...

  • Conservative Management of Small Adenomata in Ulcerative Colitis. Medlicott, S. A. C.; Jewell, L. D.; Price, L.; Fedorak, R. N.; Sherbaniuk, R. W.; Urbanski, S. J. // American Journal of Gastroenterology;Nov1997, Vol. 92 Issue 11, p2094 

    Objective and Methods: Patients with chronic ulcerative colitis may develop colitis-related dysplasia and/or sporadic adenomata. Differentiating between these two processes is important because they may dictate different therapeutic approaches. Although distinguishing features of sporadic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics